Ascendis Health: Directors' associates purchase shares on market

Associates of two Ascendis Health directors, Carl Neethling and Theunis de Bruyn, have purchased company shares, according to a JSE Limited announcement released on April 22, 2025. ACN Capital (Pty) Ltd, associated with Carl Neethling, acquired 179,264 ordinary shares at a price of 80 cents per share, resulting in a total transaction value of ZAR 143,411.20. Similarly, Calibre Investment Holdings (Pty) Ltd, associated with Theunis de Bruyn, also purchased 179,264 shares at the same price and total value. Both transactions, executed on April 14, 2025, were indirect and beneficial to the directors, with Neethling being the ultimate controlling shareholder of ACN Capital, and de Bruyn being a director and shareholder of Calibre Investment Holdings. Ascendis Health confirmed that the necessary clearance was obtained in compliance with JSE Limited Listings Requirements.